Treatments & Services

Atezolizumab in Adjuvant Setting for Advanced Squamous Cell Carcinoma of the Head and Neck

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Atezolizumab (anti PD-L1 antibody) as Adjuvant Therapy after definitive local therapy in patients with high risk locally advanced Squamous Cell Carcinoma of the Head and Neck

Disease Types: Head and Neck

Available at: AlleghanyBlacksburgRoanokeSalemWytheville

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Atezolizumab (anti PD-L1 antibody) as Adjuvant Therapy after definitive local therapy in patients with high risk locally advanced Squamous Cell Carcinoma of the Head and Neck